Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
4.760
-0.230 (-4.61%)
At close: Apr 28, 2026, 4:00 PM EDT
4.730
-0.030 (-0.63%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Atara Biotherapeutics Employees
Atara Biotherapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 139 or -90.85% compared to the previous year.
Employees
14
Change (1Y)
-139
Growth (1Y)
-90.85%
Revenue / Employee
$8,626,571
Profits / Employee
$2,334,857
Market Cap
38.93M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| NextCure | 40 |
| Werewolf Therapeutics | 39 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| INmune Bio | 21 |
| Veru Inc. | 20 |
| RenovoRx | 17 |
ATRA News
- 7 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA - PRNewsWire
- 11 days ago - ATRA Stockholders Have Rights - If You Lost Money Investing in Atara Biotherapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses - PRNewsWire
- 20 days ago - ATRA INVESTOR REMINDER: Atara Biotherapeutics, Inc. Investors Have Until May 22, 2026 To Seek Lead Plaintiff Role - GlobeNewsWire
- 6 weeks ago - Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress - Business Wire
- 6 weeks ago - Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel - Business Wire
- 2 months ago - Atara Biotherapeutics Provides a Business Update - Business Wire
- 3 months ago - Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel) - Business Wire
- 5 months ago - Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress - Business Wire